Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 408436, 2 pages

Complementary and Alternative Medicine for the Treatment of Fibromyalgia

1Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, 45276 Essen, Germany
2Department of Internal Medicine 1, Klinikum Saarbrücken, 66119 Saarbrücken, Germany
3Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, 81865 München, Germany
4Service de Médecine Interne et Thérapeutique, Centre de la Douleur, Hôtel Dieu, Université Paris Descartes, INSERM U 987, Paris, France
5Department of Rheumatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
6Rheumatology Unit, L Sacco University Hospital, Milan, Italy

Received 17 November 2013; Accepted 17 November 2013; Published 9 January 2014

Copyright © 2014 Jost Langhorst et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Häuser, S. Hayo, W. Biewer et al., “Diagnosis of fibromyalgia syndrome—a comparison of association of the medical scientific societies in Germany, survey, and American college of rheumatology criteria,” The Clinical Journal of Pain, vol. 26, no. 6, pp. 505–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Wolfe, D. J. Clauw, M.-A. Fitzcharles et al., “The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity,” Arthritis Care & Research, vol. 62, no. 5, pp. 600–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. Branco, B. Bannwarth, I. Failde et al., “Prevalence of fibromyalgia: a survey in five European countries,” Seminars in Arthritis and Rheumatism, vol. 39, no. 6, pp. 448–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Wolfe, E. Brähler, A. Hinz, and W. Häuser, “Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population,” Arthritis Care & Research, vol. 65, no. 5, pp. 777–785, 2013. View at Google Scholar
  5. R. C. Lawrence, D. T. Felson, C. G. Helmick et al., “Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II,” Arthritis & Rheumatism, vol. 58, no. 1, pp. 26–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Häuser, E. Jung, B. Erbslöh-Möller et al., “German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies,” Der Schmerz, vol. 26, no. 2, pp. 150–159, 2012 (German). View at Google Scholar
  7. R. M. Bennett, J. Jones, D. C. Turk, I. J. Russell, and L. Matallana, “An internet survey of 2,596 people with fibromyalgia,” BMC Musculoskeletal Disorders, vol. 8, article 27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. B. K. Lind, W. E. Lafferty, P. T. Tyree, P. K. Diehr, and D. E. Grembowski, “Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage,” Arthritis & Rheumatism, vol. 57, no. 1, pp. 71–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. M. Nicassio, C. Schuman, J. Kim, A. Cordova, and M. H. Weisman, “Psychosocial factors associated with complementary treatment use in fibromyalgia,” The Journal of Rheumatology, vol. 24, no. 10, pp. 2008–2013, 1997. View at Google Scholar · View at Scopus